Daiwa Securities Group
PRME icon

Daiwa Securities Group’s Prime Medicine PRME Stock Holding History

Daiwa Securities Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-398
Closed -$1K – 1378
2025
Q4 		$1K Hold
398
– – ﹤0.01% 1352
2025
Q3 		$2K Hold
398
– – ﹤0.01% 1281
2025
Q2 		$1K Hold
398
– – ﹤0.01% 1277
2025
Q1 		$1K Hold
398
– – ﹤0.01% 1244
2024
Q4 		$1K Hold
398
– – ﹤0.01% 1264
2024
Q3 		$2K Hold
398
– – ﹤0.01% 1226
2024
Q2 		$2K Hold
398
– – ﹤0.01% 1260
2024
Q1 		$3K Hold
398
– – ﹤0.01% 1246
2023
Q4 		$4K Buy
+398
New +$3.07K ﹤0.01% 1230

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Daiwa Securities Group's PRME Position: Q1 2026 in Review

Daiwa Securities Group sold out of Prime Medicine (PRME) in Q1 2026, closing a stake of 398 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in PRME in Q4 2023 and held it in 9 quarters. The position peaked at $4K in Q4 2023. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Daiwa Securities Group reported no remaining Prime Medicine position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 398 Prime Medicine shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Prime Medicine in Q4 2023 and held it in 9 quarters.
  • Daiwa Securities Group's Prime Medicine position peaked at $4K in Q4 2023.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.